has announced the addition of Kalorama Information’s new report "The World Market for Molecular Diagnostics," to their collection of Healthcare market reports.

Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and is becoming a dominant platform in clinical medicine.

Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time. At each step of the way, Kalorama Information has reported on its progress, and in this latest market research report we look at the present state of the market, and the advances that have made DNA testing routine.

Many molecular tests are CE Marked and FDA-cleared and many more are in development. The result is that molecular testing is indicated in many areas of health care.

Authored by lead Kalorama diagnostic analyst Shara Rosen, Kalorama Information’s "World Market for Molecular Diagnostics" is the most comprehensive global market report available on the emergent field of molecular diagnostics.

The report covers key platforms of molecular diagnostics and is available online.